Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut
Year: 2011
Type: review
Abstract: Liver fibrosis occurs as a wound-healing scar response following chronic liver inflammation including alcoholic liver disease, non-alcoholic steatohepatitis, viral hepatitis, cholestatic liver disease and autoimmune liver diseases. The liver has a unique vascular system within the gastrointestinal tract, as the majority of the liver's blood supply comes from the intestine through the portal vein. When the intestinal barrier function is disrupted, an increase in intestinal permeability leads to the translocation of intestine-derived bacterial products such as lipopolysaccharide (LPS) and unmethylated CpG containing DNA to the liver via the portal vein. These gut-derived bacterial products stimulate innate immune receptors, namely Toll-like receptors (TLRs), in the liver. TLRs are expressed on Kupffer cells, endothelial cells, dendritic cells, biliary epithelial cells, hepatic stellate cells, and hepatocytes. TLRs activate these cells to contribute to acute and chronic liver diseases. This review summarizes recent studies investigating the role of TLRs, intestinal microbiota and bacterial translocation in liver fibrosis, alcoholic liver disease and non-alcoholic steatohepatitis.
Source: The Journal of Physiology
Authors: Ekihiro Seki, Bernd Schnabl
Institution: University of California San Diego
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Awards: Microbiome and intestinal innate immune response in alcoholic liver disease, The UCSD Digestive Diseases Research Development Center, G1760012460, Synergistic Actions By Multiple Toll-Like Receptors in Alcoholic Liver Disease, Blocking toll-like receptor 4 signaling as therapy in hepatic fibrosis, Extracellular Matrix Regulates Hepatic Stellate Cell Activation and Fibrosis
OpenAlex ID: W2132692852
